Align Technology Performance degli utili passati
Criteri Il passato verificati 0/6
Gli utili di Align Technology sono diminuiti a un tasso medio annuo di -12.4%, mentre il settore Medical Equipment ha visto gli utili crescere a un tasso medio annuo di 18.2%. I ricavi sono cresciuti crescere a un tasso medio annuo di 1.7%. Il ritorno sul capitale proprio di Align Technology è 9.8% e ha margini netti di 10%.
Informazioni chiave
-12.35%
Tasso di crescita degli utili
-10.17%
Tasso di crescita dell'EPS
| Medical Equipment Crescita del settore | 8.90% |
| Tasso di crescita dei ricavi | 1.71% |
| Rendimento del capitale proprio | 9.77% |
| Margine netto | 9.99% |
| Prossimo aggiornamento sugli utili | 28 Oct 2026 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Seeking Alpha • Aug 07
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Summary Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow. Key risks include EU antitrust investigation, North American demand softness, iTero revenue declines, and potential activist-driven structural changes. Read the full article on Seeking Alpha
Aggiornamento narrativa • Jul 30
ALGN: Future Returns Will Depend On Execution And EU Antitrust Resolution
Align Technology's updated analyst model trims the fair value estimate by $5 to $170 as analysts factor in a slightly lower assumed revenue growth profile, a modestly higher margin outlook, and a reduced future P/E multiple, despite recent price target support from firms citing potential long term drivers and limited fundamental impact from the EU antitrust case. Analyst Commentary on Align Technology Street research on Align Technology presents a mixed picture, with some analysts highlighting long term growth drivers while others focus on valuation risks and legal overhangs.
Aggiornamento narrativa • Jul 01
ALGN: Platform Execution And Limited EU Antitrust Impact Will Drive Repricing
Align Technology's updated analyst price target moves higher to $209.07, with analysts pointing to detailed platform growth levers and limited expected fundamental impact from the EU antitrust case as key supports for the revised fair value and P/E assumptions. Analyst Commentary Analysts covering Align Technology describe a mix of supportive long-term growth drivers and near term headline risks, with recent price targets and commentary reflecting how they weigh platform execution against regulatory uncertainty.
Aggiornamento narrativa • Jun 17
ALGN: Multi-Year Upside Will Rely On Platform Expansion And Direct Fabrication
Align Technology's latest narrative update keeps the fair value unchanged at $240.00. Analysts point to a slightly lower discount rate, modestly adjusted revenue growth and profit margin assumptions, and Street research highlighting teen conversion, restorative treatment partnerships, software improvements, and direct fabrication scaling as reasons for a higher collective price target outlook.Aggiornamento narrativa • Jun 02
ALGN: Future Returns Will Rely On Execution And Elliott Engagement
Analysts have nudged their price expectations for Align Technology higher, setting a new target of $175.00. This view is supported by the belief that multiple growth levers across teen conversion, restorative treatments, peer-to-peer expansion, software evolution, and manufacturing scale may not yet be fully reflected in the current stock price.Articolo di analisi • May 18
We Like Align Technology's (NASDAQ:ALGN) Earnings For More Than Just Statutory Profit
Align Technology, Inc.'s ( NASDAQ:ALGN ) recent earnings report didn't offer any surprises, with the shares unchanged...Aggiornamento narrativa • May 12
ALGN: Higher Future Multiple Will Depend On Execution And Elliott Engagement
Narrative Update on Align Technology The updated analyst price target for Align Technology moves to $175.00 from $152.60, with analysts citing a higher assumed future P/E multiple, along with slightly lower modeled revenue growth and profit margins, as key reasons for the change. Analyst Commentary Recent research on Align Technology reflects a mix of optimism and caution, with several firms adjusting price targets and ratings over the past few months.Aggiornamento narrativa • Apr 21
ALGN: Higher Fair Value Will Follow Renewed Bullish Rating And Governance Catalyst
The analyst fair value estimate for Align Technology moves to $240 from $225, with analysts pointing to recent Street research that reflects updated views on revenue growth, margins, and P/E assumptions following multiple price target raises and positive rating actions. Analyst Commentary Recent Street research on Align Technology has leaned more constructive, with several bullish analysts updating their views on the company and its valuation framework.Aggiornamento narrativa • Apr 07
ALGN: Post Conflict Recovery And Elliott Involvement Will Drive Bullish Repricing
The analyst price target for Align Technology holds at $200, as analysts point to an improved risk/reward skew after the recent pullback and highlight the company as well positioned once regional conflict pressures ease. Analyst Commentary Bullish analysts see the recent pullback as improving the setup for Align Technology, with the stock trading below its February levels after a 15% decline linked to Middle East conflict headlines.Aggiornamento narrativa • Mar 23
ALGN: Post Conflict Demand Recovery And Elliott Engagement Will Shape Bullish Risk Reward
Align Technology's analyst fair value estimate has shifted modestly higher to about $201.69 from $198.67, as analysts point to an improved risk and reward setup following recent share weakness and a series of price target increases. These include a reiterated $200 target alongside an upgrade to Overweight at Barclays, as well as similar upward moves from several other firms.Aggiornamento narrativa • Mar 08
ALGN: Higher Fair Value Will Reflect Stronger Revenue And Margin Assumptions
The analyst fair value estimate for Align Technology has moved to $225 from $220, with the shift supported by recent price target increases across multiple firms and updated assumptions for revenue growth, profit margin, and a lower future P/E, partially offset by a higher discount rate. Analyst Commentary Recent Street research has centered on higher price targets and at least one fresh upgrade, which together align with the updated fair value estimate of US$225.Aggiornamento narrativa • Feb 22
ALGN: Margin Execution And P/E Expectations Will Shape Fairly Balanced Outlook
Align Technology's analyst price target has moved higher, with fair value estimates shifting from about $184 to roughly $199. Analysts are factoring in slightly stronger margin assumptions and a higher future P/E multiple, supported by a series of recent price target increases across major firms.Aggiornamento narrativa • Feb 08
ALGN: Future Multiple Compression Risk Will Test Execution Dependent Story
Analysts have lifted their price expectations for Align Technology, reflected in a higher implied fair value from about $140.00 to roughly $152.60, citing updated assumptions around revenue growth, profitability and future P/E multiples in recent research. Analyst Commentary Recent research activity around Align Technology has centered on revisiting fair value frameworks, with several firms adjusting price targets based on updated views of revenue potential, profitability and appropriate P/E multiples.Aggiornamento narrativa • Jan 25
ALGN: Q3 Volume Strength And Visibility Concerns Will Shape Balanced Outlook
Analysts have nudged their fair value estimate for Align Technology up by about $3 to $183.87, citing recent price target increases that reflect improved confidence in the company’s volume trends and revenue visibility following Q3 results. Analyst Commentary Recent research on Align Technology highlights a mix of optimism on execution following Q3 and ongoing caution around demand visibility and expectations for upcoming quarters.Aggiornamento narrativa • Jan 10
ALGN: Q3 Volume Strength And Cautious Outlook Will Shape Fairly Balanced Expectations
Narrative Update The analyst price target for Align Technology is now framed by a modestly higher intrinsic value estimate of about $180.47 per share, as analysts weigh recent target revisions around $200 and $170 against updated assumptions for growth, margins and future P/E. Analyst Commentary Recent Street commentary on Align Technology reflects a mix of renewed confidence in execution and ongoing caution around revenue visibility and the path to growth.Articolo di analisi • Jan 04
Returns On Capital Are Showing Encouraging Signs At Align Technology (NASDAQ:ALGN)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Aggiornamento narrativa • Dec 21
ALGN: Q3 Volume Gains Will Support Renewed Confidence In Upcoming Revenue Ramp
Analysts have modestly raised their price target on Align Technology to $200 from $190, reflecting improved confidence in management's restored revenue visibility and Q4 execution following broad-based Q3 volume upside, even as valuation assumptions and long term growth forecasts remain largely unchanged. Analyst Commentary Recent Street commentary on Align Technology reflects a more constructive stance on near term execution, balanced by lingering questions around the durability of growth and visibility into 2025.Aggiornamento narrativa • Dec 07
ALGN: Q3 Volume Strength Will Support Confidence In Upcoming Revenue Ramp
Analysts have nudged their average price target on Align Technology modestly higher, by roughly $4 to about $184, as stronger than expected Q3 volume trends and improved visibility into hitting year end revenue goals outweighed lingering concerns about the pace of sequential improvement. Analyst Commentary Recent research updates reflect a generally constructive stance on Align Technology, with some lingering caution around execution into Q4 and beyond.Aggiornamento narrativa • Nov 23
ALGN: Recent Revenue Upside Will Improve Confidence In Forward Momentum
Analysts have raised their price target for Align Technology from $190 to $200 per share, citing improved revenue visibility and a stronger than expected third-quarter performance. Analyst Commentary Analysts have weighed in with both optimism and caution regarding Align Technology's outlook, highlighted by recent changes in price targets and ratings.Aggiornamento narrativa • Nov 08
ALGN: Volume Upside and Margin Strength Will Drive a Positive Outlook
Analysts have increased their price target for Align Technology from $175.07 to $180.50, citing improved revenue growth prospects, a stronger profit margin outlook, and management's recent success in delivering volume upside despite concerns about seasonality. Analyst Commentary Recent analyst updates on Align Technology reflect a range of perspectives, highlighting both positive developments and ongoing concerns in the company's outlook.Aggiornamento narrativa • Oct 24
Digital Workflow Improvements And Market Weakness Will Shape The Coming Year
Analysts have lowered their price target for Align Technology by approximately $5 to $175. They cite slightly softer revenue growth projections, modestly reduced profit margin expectations, and increased uncertainty around guidance for the upcoming quarters.Aggiornamento narrativa • Oct 10
Emerging Markets And Digital Workflow Will Fuel Future Success
Analysts have modestly lowered their price target for Align Technology, trimming it by approximately $6 to $180. Updated industry surveys and company results reflect both ongoing optimism and continued challenges in the dental market.Seeking Alpha • Mar 07
Align Technology: Brace Yourself, This Stock Is Undervalued
Summary Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation. ALGN's market potential is strong, particularly with younger demographics, although recent revenue per shipment has softened. Read the full article on Seeking AlphaRipartizione dei ricavi e delle spese
Ripartizione dei ricavi e delle spese
Come Align Technology guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storico di utili e ricavi
| Data | Ricavi | Utili | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 30 Jun 26 | 4,140 | 414 | 1,787 | 377 |
| 31 Mar 26 | 4,096 | 430 | 1,774 | 371 |
| 31 Dec 25 | 4,035 | 410 | 1,756 | 370 |
| 30 Sep 25 | 3,983 | 378 | 1,739 | 382 |
| 30 Jun 25 | 3,965 | 438 | 1,755 | 374 |
| 31 Mar 25 | 3,981 | 410 | 1,759 | 370 |
| 31 Dec 24 | 3,999 | 421 | 1,763 | 364 |
| 30 Sep 24 | 3,961 | 442 | 1,741 | 351 |
| 30 Jun 24 | 3,943 | 447 | 1,715 | 355 |
| 31 Mar 24 | 3,917 | 462 | 1,716 | 351 |
| 31 Dec 23 | 3,862 | 445 | 1,703 | 347 |
| 30 Sep 23 | 3,807 | 363 | 1,711 | 348 |
| 30 Jun 23 | 3,737 | 314 | 1,701 | 336 |
| 31 Mar 23 | 3,705 | 315 | 1,675 | 321 |
| 31 Dec 22 | 3,735 | 362 | 1,674 | 305 |
| 30 Sep 22 | 3,864 | 511 | 1,716 | 294 |
| 30 Jun 22 | 3,990 | 619 | 1,745 | 283 |
| 31 Mar 22 | 4,031 | 706 | 1,751 | 268 |
| 31 Dec 21 | 3,953 | 772 | 1,709 | 250 |
| 30 Sep 21 | 3,756 | 740 | 1,606 | 227 |
| 30 Jun 21 | 3,474 | 698 | 1,490 | 206 |
| 31 Mar 21 | 2,816 | 458 | 1,315 | 188 |
| 31 Dec 20 | 2,472 | 1,776 | 1,201 | 175 |
| 30 Sep 20 | 2,287 | 1,738 | 1,132 | 168 |
| 30 Jun 20 | 2,160 | 1,701 | 1,097 | 163 |
| 31 Mar 20 | 2,409 | 1,889 | 1,108 | 161 |
| 31 Dec 19 | 2,407 | 443 | 1,072 | 157 |
| 30 Sep 19 | 2,291 | 419 | 1,019 | 152 |
| 30 Jun 19 | 2,189 | 417 | 956 | 145 |
| 31 Mar 19 | 2,079 | 376 | 900 | 137 |
| 31 Dec 18 | 1,966 | 400 | 852 | 129 |
| 30 Sep 18 | 1,854 | 313 | 808 | 119 |
| 30 Jun 18 | 1,734 | 295 | 763 | 111 |
| 31 Mar 18 | 1,600 | 258 | 714 | 104 |
| 31 Dec 17 | 1,473 | 231 | 666 | 98 |
| 30 Sep 17 | 1,345 | 269 | 614 | 93 |
| 30 Jun 17 | 1,239 | 238 | 571 | 89 |
| 31 Mar 17 | 1,151 | 219 | 530 | 83 |
| 31 Dec 16 | 1,080 | 190 | 491 | 76 |
| 30 Sep 16 | 1,017 | 191 | 460 | 68 |
| 30 Jun 16 | 946 | 167 | 435 | 65 |
| 31 Mar 16 | 886 | 148 | 414 | 62 |
| 31 Dec 15 | 845 | 144 | 390 | 61 |
| 30 Sep 15 | 814 | 135 | 377 | 61 |
Guadagni di qualità: ALGN ha un grande una tantum perdita di $190.7M che ha avuto un impatto sui suoi ultimi 12 mesi di risultati finanziari pari a 30th June, 2026.
Margine di profitto in crescita: Gli attuali margini di profitto netti di ALGN (10%) sono inferiori rispetto allo scorso anno (11%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: Gli utili di ALGN sono diminuiti del 12.4% all'anno negli ultimi 5 anni.
Accelerare la crescita: ALGN ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.
Guadagni vs Settore: ALGN ha avuto una crescita negativa degli utili ( -5.5% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Medical Equipment ( 20.4% ).
Rendimento del capitale proprio
ROE elevato: Il Return on Equity ( 9.8% ) di ALGN è considerato basso.
Rendimento delle attività
Rendimento del capitale investito
Scoprire le aziende con forti performance passate
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/09/14 11:31 |
| Prezzo dell'azione a fine giornata | 2026/09/14 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Align Technology, Inc. è coperta da 43 analisti. 16 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Jeffrey Johnson | Baird |
| Glen Santangelo | Barclays |
| Charley Jones | Barrington Research Associates, Inc. |